Home Health & Wellness How Continuous Glucose Monitoring (CGM) Could Aid in Managing Sleep Apnoea

How Continuous Glucose Monitoring (CGM) Could Aid in Managing Sleep Apnoea

Reading Time: 4 minutes

Sleep apnoea is one of the most widespread sleep disorders known to impact millions of people around the world, manifesting as periods of breathlessness while asleep. It commonly coexists with several other medical conditions, including cardiovascular problems and diabetes mellitus. Treatment alternatives are available, but with the introduction of new technology, continuous glucose monitoring (CGM), clinical studies show the potential benefits of novel techniques for the management of sleep apnoea. In this paper, we will explore how CGM could help Control sleep apnea transform the landscape of sleep apnoea treatment.

Sleep apnoea in CGM

In studying sleep apnoea, the interferences with normal breathing patterns that occur during sleep are all that determine a disturbed state of sleep and not enough oxygen. There are two major forms: obstructive sleep apnoea (OSA), caused by airway blockage, and central sleep apnoea (CSA), due to a failure of the brain to transmit signals to the muscles for breathing. These two types also contribute to fatigue, poor cognitive function in the daytime, and an elevated risk of heart disease and stroke.

The role of glucose levels 

The role that glucose levels play in sleep regulation can be deemed as crucial because glucose is the principal energy source for the body. Moreover, individuals with sleep apnoea often have higher insulin resistance and are at increased risk of developing type 2 diabetes.

CGM: A game-changer in diabetes management

Diabetes control has shifted to a new level of technology. CGM systems monitor glucose levels in real time, allowing blood sugar variations to be tracked during both day and night cycles. Although initially created with diabetes management in mind, the advancements in CGM technology have made it possible to assess metabolic health more broadly, beyond glycemic control.

It has been recently discovered that glucose dysregulation is closely related to the severity of sleep apnoea. When the level of nighttime glucose is higher, it corresponds to an increased number of apnoea episodes and low-quality sleep. On the other hand, when a person has stabilised their glucose level, then the sleep parameters may be improved, as well as a decrease in apnoea severity.

Potential benefits of CGM in sleep apnoea management

Detecting a condition at an earlier stage and evaluating its progress is possible through CGM, which permits unrelenting sugar monitoring at night in the presence of nocturnal hyperglycemia that develops because of sleep apnoea.

  • Early detection and monitoring. In the arena of personalised treatment strategies, healthcare providers can optimise the use of CGM data. For example, when it is integrated with sleep studies to design and apply a course of action that effectively suits metabolic and sleep-individualised requirements,.
  • Optimisation of lifestyle interventions. CGM data can help people make well-considered lifestyle choices, such as changes in diet and exercise, that can improve not only the control of glucose levels but also sleep quality.
  • Enhanced compliance and adherence. The effectiveness of therapies for sleep apnoea may be increased if patients choose such non-invasive and convenient ways as CGM devices for monitoring their conditions, which can also have a positive impact on treatment results.

Challenges and considerations 

There are several challenges to consider when implementing CGM in sleep apnoea management. These challenges involve establishing the CGM’s effectiveness, overcoming cost obstacles, and guaranteeing patient compliance and acceptance of this new technology. Furthermore, gaining regulatory approval for using it off-label in sleep medicine could be a barrier without sufficient supportive evidence.

Future directions and research opportunities

CGM technology is heading in the future direction of sleep apnoea management due to advancements in the field, which would offer more potential for enhanced patient outcomes as well as quality of life. In order for future studies to be successful, they must prioritise identifying the best timing for initiation, effective methods of follow-up and ongoing support, relevant measures of effectiveness and feasibility, and exploration into potential mediating variables.

  • Longitudinal research is needed to evaluate the effects of CGM-led interventions on sleep apnoea’s degree of severity and its comorbidities.
  • The development of user-friendly continuous glucose monitoring (CGM) devices to cater for sleep apnoea monitoring and they should have capabilities like sleep tracking and respiratory event detection.
  • In the meantime, another analysis methodology that may be applicable in economic evaluations of CGM incorporation into standard sleep apnoea treatment guidelines is cost-effectiveness analysis.


An emerging concept in sleep apnoea treatment is the use of CGM, which deals with metabolic abnormalities. Because CGM tools continuously record glucose concentration in the bloodstream, they provide a wealth of information that can elucidate the relationship between glycemic control and sleep quality.

This continuous monitoring can uncover patterns of glucose fluctuations that are closely tied to sleep disturbances, offering potential insights into personalised treatment plans.

By identifying periods of impaired glucose regulation during sleep, healthcare providers can tailor interventions that target both sleep apnoea and concurrent metabolic issues more effectively. The data collected through CGM could also lead to a better understanding of how lifestyle changes, such as diet and exercise, impact both sleep and glucose levels.

Over time, this approach may not only improve sleep quality but also enhance overall metabolic health, creating a comprehensive care strategy for patients. Integrating CGM with other health monitoring devices could provide a more holistic view of a patient’s health status, thereby improving diagnostic accuracy and treatment outcomes.

Ellen Diamond, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.

© Copyright 2014–2034 Psychreg Ltd